Stockscreener 앱 받기
14.43
4.12%
-0.62
시간 외 거래:
14.44
0.010
+0.07%
전일 마감가:
$15.05
열려 있는:
$14.78
하루 거래량:
21,989
Relative Volume:
0.50
시가총액:
$348.45M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-1.3176
EPS:
-10.9518
순현금흐름:
$-18.07M
1주 성능:
+5.79%
1개월 성능:
+17.13%
6개월 성능:
+39.83%
1년 성능:
+61.23%
1일 변동 폭
$14.43
$15.09
1주일 범위
$13.10
$15.69
52주 변동 폭
$5.742
$16.90
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
14.43 | 348.45M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by Geode Capital Management LLC - Defense World
Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade - MSN
What Makes Benitec Biopharma (BNTC) a New Buy Stock - Yahoo Finance
(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance
Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
JMP Securities Boosts Benitec Biopharma (NASDAQ:BNTC) Price Target to $20.00 - Defense World
Benitec Biopharma (BNTC) Stock Price Target Increased Amid Promi - GuruFocus
Benitec stock price target raised to $20 at JMP Securities - Investing.com Australia
Benitec stock price target raised to $20 at JMP Securities By Investing.com - Investing.com India
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World
Q3 EPS Forecast for Benitec Biopharma Boosted by Analyst - Defense World
Suvretta capital management buys $211,736 in Benitec Biopharma shares By Investing.com - Investing.com Canada
Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
Top 5 Small-cap Biotech Stocks of 2025 - Nasdaq
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 900,000 Shares of Stock - MarketBeat
Benitec Biopharma completes stock and warrant offerings By Investing.com - Investing.com Australia
Suvretta capital purchases $11.7m in Benitec Biopharma shares By Investing.com - Investing.com India
Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market! - TipRanks
Benitec Biopharma completes stock and warrant offerings - Investing.com India
Suvretta capital purchases $11.7m in Benitec Biopharma shares - Investing.com
Benitec Biopharma inks deal granting stock resale rights - Investing.com India
Benitec Biopharma inks deal granting stock resale rights By Investing.com - Investing.com Canada
Benitec Biopharma prices $30M securities offerings - MSN
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire
Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering - TipRanks
Benitec Biopharma Prices $30 Million Equity Offerings - MarketScreener
(BNTC) Trading Report - news.stocktradersdaily.com
Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World
H.C. Wainwright maintains Buy on Benitec BioPharma stock By Investing.com - Investing.com Australia
H.C. Wainwright maintains Buy on Benitec BioPharma stock - Investing.com
Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Up 17.6% in February - Defense World
Benitec Biopharma stock soars to 52-week high of $16.2 By Investing.com - Investing.com Australia
Benitec Biopharma stock soars to 52-week high of $16.2 - Investing.com
Benitec reports progress in OPMD swallowing function study By Investing.com - Investing.com South Africa
Benitec Biopharma Reports Positive Interim Results For BB-301 Gene Therapy In OPMD Clinical Trial - RTTNews
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):